$368 Million is the total value of Krensavage Asset Management, LLC's 11 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 15.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Sell | UNITED THERAPEUTICS CORP | $57,178,000 | +11.7% | 472,548 | -12.4% | 15.56% | -5.5% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $55,353,000 | +33.4% | 493,170 | +6.7% | 15.06% | +12.8% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $49,699,000 | +17.2% | 79,691 | -8.2% | 13.52% | -0.8% |
| BIIB | Buy | BIOGEN INC | $40,512,000 | +15.6% | 151,420 | +36.7% | 11.02% | -2.2% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $38,315,000 | +6.4% | 763,103 | +9.0% | 10.42% | -10.0% |
| TARO | Buy | TARO PHARMACEUTICAL INDUS | $34,675,000 | +16.3% | 521,507 | +7.0% | 9.43% | -1.7% |
| MCK | Sell | MCKESSON CORP | $33,161,000 | +12.3% | 216,142 | -1.0% | 9.02% | -5.0% |
| ALKS | Buy | ALKERMES PLC | $30,362,000 | +80.3% | 1,564,665 | +34.0% | 8.26% | +52.5% |
| RTIX | Buy | RTI SURGICAL HDS INC | $18,608,000 | +170.2% | 5,851,572 | +45.3% | 5.06% | +128.5% |
| IVC | Sell | INVACARE CORP | $5,583,000 | -15.3% | 876,421 | -1.2% | 1.52% | -28.3% |
| ANAB | Sell | ANAPTYSBIO INC | $4,129,000 | -34.2% | 184,846 | -58.4% | 1.12% | -44.3% |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -3,639 | -100.0% | -0.01% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -117,755 | -100.0% | -2.83% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-08-20
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.